Heterocyclic inhibitors of PCSK9
US11091466B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2018 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | Mar 16, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/366
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, PCSK9, or a pharmaceutically acceptable salt, solvate, prodrug or polymorph thereof, and to compositions and formulations comprising such compounds, and methods of using and making such compounds. Compounds include comprising of Formula (I): (I) wherein A, D and Q are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.